Stockreport

Corcept Tanks on FDA's CRL to Relacorilant NDA in Hypercortisolism [Yahoo! Finance]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF for its proprietary, selective cortisol modulator, relacorilant, to treat patients with hypercortisolism (Cushing's syndrome). Shares of Corcept plunged 50.4% on Dec. [Read more]